Should We Interrupt Oral Anticoagulation Before Percutaneous Coronary Intervention? A National Survey of UK Interventional Cardiologists

Heart Lung Circ. 2022 Jan;31(1):e5-e6. doi: 10.1016/j.hlc.2021.08.002. Epub 2021 Aug 25.

Authors

Annette M Maznyczka¹, Alex Hobson², Nick Curzen³, Peter A J Haworth²

Affiliations

¹ Cardiology Department, Portsmouth Hospitals University NHS Trust, Portsmouth, UK. Electronic address: amaznyczka@nhs.net.
² Cardiology Department, Portsmouth Hospitals University NHS Trust, Portsmouth, UK.
³ Faculty of Medicine, University of Southampton & Wessex Cardiac Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

PMID: 34454839
DOI: 10.1016/j.hlc.2021.08.002

No abstract available

Keywords: Direct oral anticoagulant; Guidelines; Percutaneous coronary intervention; Warfarin.

Publication types

Letter

MeSH terms

Administration, Oral
Anticoagulants / therapeutic use
Blood Coagulation
Cardiologists*
Humans
Percutaneous Coronary Intervention*
Treatment Outcome
United Kingdom / epidemiology

Substances

Anticoagulants